AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15347634 — intervention group
Group type: COMPARATOR
Intervention: Trimethoprim/sulfamethoxazole 160/800 mg orally twice daily for 7 days
Number of subjects: 455
Study 15347634 — intervention group
Group type: COMPARATOR
Intervention: Norfloxacin 400 mg orally twice daily for 7 days
Number of subjects: 455
Study 11174282 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemoclips (HC)
Number of subjects: 113
Study 11174282 — intervention group
Group type: COMPARATOR
Intervention: Heat probe (HP)
Number of subjects: 113
Study 9821477 — intervention group
Group type: EXPERIMENTAL
Intervention: Mizolastine 10 mg o.d. for 4 weeks
Number of subjects: 257
Study 9821477 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 4 weeks
Number of subjects: 257
Study 8031419 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone (10 mg bolus)
Number of subjects: 7
Study 8031419 — intervention group
Group type: EXPERIMENTAL
Intervention: CRH (100 micrograms bolus)
Number of subjects: 7
Study 8031419 — intervention group
Group type: EXPERIMENTAL
Intervention: Methoxamine (6 micrograms/kg per min over 3 h)
Number of subjects: 7
Study 8031419 — intervention group
Group type: EXPERIMENTAL
Intervention: Methoxamine plus CRH
Number of subjects: 7
Study 8031419 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone plus CRH
Number of subjects: 7
Study 8031419 — intervention group
Group type: EXPERIMENTAL
Intervention: Methoxamine plus naloxone
Number of subjects: 7
Study 8031419 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 7
Study 1969244 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonazepam treatment
Number of subjects: 19
Study 432800 — intervention group
Group type: EXPERIMENTAL
Intervention: Filtered fluids
Number of subjects: 266
Study 432800 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin-hydrocortisone combinations
Number of subjects: 266
Study 432800 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 266
Study 30900422 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral groin puncture-single trans-septal ablation (UG-ST)
Number of subjects: 222
Study 30900422 — intervention group
Group type: COMPARATOR
Intervention: Bilateral groin puncture-double trans-septal ablation (BG-DT)
Number of subjects: 222
Study 27669638 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic capsule
Number of subjects: 60
Study 27669638 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 25511816 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid angioplasty and stenting (CAS)
Number of subjects: 150
Study 25511816 — intervention group
Group type: COMPARATOR
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 150
Study 25511816 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive function tests
Number of subjects: 150
Study 23490388 — intervention group
Group type: EXPERIMENTAL
Intervention: Telbivudine treatment for 4 years
Number of subjects: 596
Study 21232155 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine-free cigarettes (Quest 3) for six weeks + NRT patches, gum and/or lozenges for eight weeks
Number of subjects: 1410
Study 21232155 — intervention group
Group type: COMPARATOR
Intervention: NRT patches, gum and/or lozenges for eight weeks
Number of subjects: 1410
Study 19597362 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma-focused group therapy
Number of subjects: 166
Study 19597362 — intervention group
Group type: EXPERIMENTAL
Intervention: Present-focused group therapy
Number of subjects: 166
Study 19597362 — intervention group
Group type: COMPARATOR
Intervention: Waitlist group (control)
Number of subjects: 166
Study 17191036 — intervention group
Group type: EXPERIMENTAL
Intervention: NGF hydrocortisone 0.25% cream
Number of subjects: 20
Study 17191036 — intervention group
Group type: EXPERIMENTAL
Intervention: NGF hydrocortisone 0.5% cream
Number of subjects: 20
Study 17191036 — intervention group
Group type: EXPERIMENTAL
Intervention: NGF hydrocortisone 1.0% cream
Number of subjects: 20
Study 17191036 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogalen cream (hydrocortisone 1.0%)
Number of subjects: 20
Study 17191036 — intervention group
Group type: COMPARATOR
Intervention: Soventol hydrocortisone (hydrocortisone acetate 0.25%)
Number of subjects: 20
Study 17191036 — intervention group
Group type: COMPARATOR
Intervention: Hydroderm HC 0.5% cream (hydrocortisone 0.5%)
Number of subjects: 20
Study 17191036 — intervention group
Group type: COMPARATOR
Intervention: Placebo (vehicle of test preparations)
Number of subjects: 20
Study 15471835 — intervention group
Group type: EXPERIMENTAL
Intervention: 123I‐labeled N‐(3‐iodopropene‐2‐yl)‐2beta‐carbomethoxy‐3beta‐(4‐chlorophenyl) tropane and SPECT
Number of subjects: 6
Study 11450886 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral cefixime 8 mg/kg/day for 10 days
Number of subjects: 54
Study 11450886 — intervention group
Group type: COMPARATOR
Intervention: Initial intramuscular ceftizoxime 50 mg/kg twice a day for 2 days followed by oral cefixime for 8 days
Number of subjects: 54
Study 9931851 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant 3-week intravenous PGE1 treatment
Number of subjects: 0
Study 9931851 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 8128173 — intervention group
Group type: EXPERIMENTAL
Intervention: Glyceryl trinitrate (GTN), 2.6 mg, administered 2 hours before ingestion of 500 ml meat soup
Number of subjects: 10
Study 8128173 — intervention group
Group type: COMPARATOR
Intervention: No drug administration (Control)
Number of subjects: 10
Study 2644815 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone phosphate (0.6 mg/kg per day in 4 doses for 4 days)
Number of subjects: 31
Study 2644815 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 49472 — intervention group
Group type: EXPERIMENTAL
Intervention: Carrying a 15 kg weight in a shopping basket
Number of subjects: 13
Study 49472 — intervention group
Group type: COMPARATOR
Intervention: Carrying a 15 kg weight in a rucksack on the back
Number of subjects: 13
Study 49472 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained handgrip test
Number of subjects: 13
Study 30691471 — intervention group
Group type: EXPERIMENTAL
Intervention: Vienna Food Record
Number of subjects: 35
Study 30691471 — intervention group
Group type: COMPARATOR
Intervention: Weighed food record
Number of subjects: 35
Study 28121648 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral synbiotic (Lactobacillus plantarum and fructo‐oligosaccharides) administered daily for 7 days
Number of subjects: 11
Study 28121648 — intervention group
Group type: COMPARATOR
Intervention: Control group (no synbiotic treatment)
Number of subjects: 11
Study 25841588 — intervention group
Group type: EXPERIMENTAL
Intervention: Eating Attitudes Test‐26 (EAT‐26)
Number of subjects: 320
Study 25841588 — intervention group
Group type: EXPERIMENTAL
Intervention: Questionnaire of Eating and Weight Patterns–Revised (QEWP‐R)
Number of subjects: 320
Study 25841588 — intervention group
Group type: COMPARATOR
Intervention: Comparison of patients with BED vs those without BED
Number of subjects: 320
Study 25841588 — intervention group
Group type: COMPARATOR
Intervention: Hospital admissions related to T2DM or any other condition
Number of subjects: 320
Study 23784076 — intervention group
Group type: EXPERIMENTAL
Intervention: Printed intervention
Number of subjects: 935
Study 23784076 — intervention group
Group type: COMPARATOR
Intervention: Web-based intervention
Number of subjects: 935
Study 23784076 — intervention group
Group type: EXPERIMENTAL
Intervention: Environmental intervention components
Number of subjects: 935
Study 23784076 — intervention group
Group type: COMPARATOR
Intervention: Basic intervention components
Number of subjects: 935
Study 21183937 — intervention group
Group type: COMPARATOR
Intervention: diet only
Number of subjects: 126
Study 21183937 — intervention group
Group type: COMPARATOR
Intervention: diet + aerobic training
Number of subjects: 126
Study 21183937 — intervention group
Group type: COMPARATOR
Intervention: diet + resistance training
Number of subjects: 126
Study 19933787 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsigned statement
Number of subjects: 480
Study 19933787 — intervention group
Group type: EXPERIMENTAL
Intervention: Opinion leader statement
Number of subjects: 480
Study 19933787 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 480
Study 16730718 — intervention group
Group type: EXPERIMENTAL
Intervention: Day 2 embryo transfer (ET)
Number of subjects: 242
Study 16730718 — intervention group
Group type: COMPARATOR
Intervention: Day 3 embryo transfer (ET)
Number of subjects: 242
Study 15585899 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimanual task condition
Number of subjects: 94
Study 15585899 — intervention group
Group type: COMPARATOR
Intervention: Unimanual task condition
Number of subjects: 94
Study 15585899 — intervention group
Group type: EXPERIMENTAL
Intervention: Adults and elderly
Number of subjects: 94
Study 15585899 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger children
Number of subjects: 94
Study 15585899 — intervention group
Group type: EXPERIMENTAL
Intervention: Developmental trend
Number of subjects: 94
Study 11748512 — intervention group
Group type: EXPERIMENTAL
Intervention: Anesthesiology residents
Number of subjects: 61
Study 11748512 — intervention group
Group type: EXPERIMENTAL
Intervention: Anesthesiology attending physicians
Number of subjects: 61
Study 11748512 — intervention group
Group type: COMPARATOR
Intervention: Radiology residents (control group)
Number of subjects: 61
Study 9408711 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 8123399 — intervention group
Group type: EXPERIMENTAL
Intervention: diclofenac 75 mg i.m. 20 min before operation
Number of subjects: 34
Study 8123399 — intervention group
Group type: COMPARATOR
Intervention: saline placebo
Number of subjects: 34
Study 3572036 — intervention group
Group type: EXPERIMENTAL
Intervention: Abbreviated course of doxycycline (until afebrile plus one day)
Number of subjects: 50
Study 3572036 — intervention group
Group type: COMPARATOR
Intervention: One-week regimen of doxycycline
Number of subjects: 50
Study 29459111 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol anesthesia
Number of subjects: 62
Study 29459111 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane anesthesia
Number of subjects: 62
Study 29459111 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 62
Study 27900707 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoroscopy-guided biodegradable spacer implantation (InSpace™ system) under local anesthesia
Number of subjects: 15
Study 24105106 — intervention group
Group type: EXPERIMENTAL
Intervention: Triflusal (300, 600, 900 mg single doses; 600 mg once daily for 7 days)
Number of subjects: 30
Study 24105106 — intervention group
Group type: EXPERIMENTAL
Intervention: HTB (metabolite of Triflusal)
Number of subjects: 30
Study 24105106 — intervention group
Group type: EXPERIMENTAL
Intervention: Triflusal (multiple doses of 600 mg once daily for 7 days)
Number of subjects: 30
Study 24105106 — intervention group
Group type: EXPERIMENTAL
Intervention: Triflusal and HTB (pharmacokinetics)
Number of subjects: 30
Study 23896185 — intervention group
Group type: EXPERIMENTAL
Intervention: Flow restrictors (FRs) added to liquid medicine bottles
Number of subjects: 110
Study 23896185 — intervention group
Group type: COMPARATOR
Intervention: Control bottles without FRs (open and incompletely closed)
Number of subjects: 110
Study 20865678 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training, 3 times a week, at 60-80% of maximal heart rate for 6 weeks (Ex, n = 32)
Number of subjects: 64
Study 20865678 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 32)
Number of subjects: 64
Study 18053662 — intervention group
Group type: EXPERIMENTAL
Intervention: DMPC/DHPC bicelles (molar ratio 2/1)
Number of subjects: 0
Study 15902852 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-bearing posterior-stabilized prosthesis (LPS)
Number of subjects: 210
Study 15902852 — intervention group
Group type: COMPARATOR
Intervention: Meniscal-bearing prosthesis (MBK)
Number of subjects: 210
Study 12488375 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 26
Study 12488375 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 26
Study 10675181 — intervention group
Group type: EXPERIMENTAL
Intervention: Mammography screening
Number of subjects: 0
Study 10675181 — intervention group
Group type: COMPARATOR
Intervention: Other trials (not adequately randomised)
Number of subjects: 0
Study 10675181 — intervention group
Group type: COMPARATOR
Intervention: Swedish meta-analysis
Number of subjects: 0
Study 10675181 — intervention group
Group type: EXPERIMENTAL
Intervention: Mammography screening (biennially for 12 years)
Number of subjects: 0
Study 10675181 — intervention group
Group type: COMPARATOR
Intervention: Swedish trials (excluding Malmo trial)
Number of subjects: 0
Study 9148318 — intervention group
Group type: EXPERIMENTAL
Intervention: Attractive target
Number of subjects: 176
Study 9148318 — intervention group
Group type: EXPERIMENTAL
Intervention: Unattractive target
Number of subjects: 176
Study 9148318 — intervention group
Group type: EXPERIMENTAL
Intervention: Male target
Number of subjects: 176
Study 9148318 — intervention group
Group type: COMPARATOR
Intervention: Female target
Number of subjects: 176
Study 1536156 — intervention group
Group type: EXPERIMENTAL
Intervention: Halon 1211 (1,000 ppm) during exercise
Number of subjects: 10
Study 1536156 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 6531968 — intervention group
Group type: EXPERIMENTAL
Intervention: RA27/3 vaccine strain
Number of subjects: 98
Study 6531968 — intervention group
Group type: EXPERIMENTAL
Intervention: BRD‐2 vaccine strain
Number of subjects: 98
Study 6531968 — intervention group
Group type: COMPARATOR
Intervention: Uninoculated group
Number of subjects: 98
Study 30756142 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 ml of anaesthetic solution
Number of subjects: 90
Study 30756142 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 ml anaesthetic solution
Number of subjects: 90
Study 30756142 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90
Study 30095289 — intervention group
Group type: EXPERIMENTAL
Intervention: Baska FESS mask
Number of subjects: 100
Study 30095289 — intervention group
Group type: COMPARATOR
Intervention: LMA Supreme
Number of subjects: 100
Study 27350371 — intervention group
Group type: EXPERIMENTAL
Intervention: 'Stand still ..., and move on' intervention
Number of subjects: 185
Study 27350371 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual (Control)
Number of subjects: 185
Study 25222285 — intervention group
Group type: EXPERIMENTAL
Intervention: GO2KA1 supplementation
Number of subjects: 0
Study 25222285 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 22773741 — intervention group
Group type: EXPERIMENTAL
Intervention: ceftolozane/tazobactam 1.5 g administered every 8 h via a 60 min infusion
Number of subjects: 51
Study 22773741 — intervention group
Group type: COMPARATOR
Intervention: piperacillin/tazobactam 4.5 g administered every 6 h via a 30 min infusion
Number of subjects: 51
Study 20186971 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic massage
Number of subjects: 68
Study 20186971 — intervention group
Group type: COMPARATOR
Intervention: Thermotherapy
Number of subjects: 68
Study 20186971 — intervention group
Group type: COMPARATOR
Intervention: Relaxing room therapy
Number of subjects: 68
Study 17413956 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0% carboxymethylcellulose (CMC) mid-viscosity artificial tear
Number of subjects: 607
Study 17413956 — intervention group
Group type: COMPARATOR
Intervention: Low-viscosity tears
Number of subjects: 607
Study 17044658 — intervention group
Group type: EXPERIMENTAL
Intervention: Informed consent process by physicians
Number of subjects: 448
Study 17044658 — intervention group
Group type: EXPERIMENTAL
Intervention: Information sufficiency on the informed consent sheet
Number of subjects: 448
Study 17044658 — intervention group
Group type: EXPERIMENTAL
Intervention: Influence of relatives and friends on patient decision
Number of subjects: 448
Study 17044658 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeting patients for informed consent
Number of subjects: 448
Study 17044658 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentives for patients
Number of subjects: 448
Study 14557564 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 U Botulinum toxin type A (BTXA)
Number of subjects: 16
Study 14557564 — intervention group
Group type: COMPARATOR
Intervention: Pure saline (placebo)
Number of subjects: 16
Study 14557564 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin administered on day 28
Number of subjects: 16
Study 11039685 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjoint Family Therapy (CFT)
Number of subjects: 40
Study 11039685 — intervention group
Group type: EXPERIMENTAL
Intervention: Separated Family Therapy (SFT)
Number of subjects: 40
Study 11039685 — intervention group
Group type: COMPARATOR
Intervention: Both CFT and SFT
Number of subjects: 40
Study 8697144 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon therapy (IFN-alpha and IFN-gamma)
Number of subjects: 25
Study 8697144 — intervention group
Group type: COMPARATOR
Intervention: Busulfan (BU) therapy
Number of subjects: 25
Study 1833543 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 ml lignocaine, 0.5% (L) in rheumatology setting
Number of subjects: 41
Study 1833543 — intervention group
Group type: COMPARATOR
Intervention: 5 ml isotonic saline (S) in rheumatology setting
Number of subjects: 41
Study 1833543 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 ml lignocaine, 0.5% (L) in general practice setting
Number of subjects: 41
Study 1833543 — intervention group
Group type: COMPARATOR
Intervention: 5 ml isotonic saline (S) in general practice setting
Number of subjects: 41
Study 6345489 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy adjuvant administered prior to definitive irradiation
Number of subjects: 500
Study 6345489 — intervention group
Group type: EXPERIMENTAL
Intervention: Oropharynx patients (T3-4 primaries)
Number of subjects: 500
Study 6345489 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral cavity tumors (T3-4 primaries)
Number of subjects: 500
Study 6345489 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with controlled primary and cervical nodes
Number of subjects: 500
Study 6345489 — intervention group
Group type: EXPERIMENTAL
Intervention: N0 patients with oropharyngeal cancers
Number of subjects: 500
Study 6345489 — intervention group
Group type: EXPERIMENTAL
Intervention: N3 nodes associated with primaries
Number of subjects: 500
Study 6345489 — intervention group
Group type: EXPERIMENTAL
Intervention: N3 oropharyngeal deposits
Number of subjects: 500
Study 6345489 — intervention group
Group type: EXPERIMENTAL
Intervention: N3 nodes secondary to oral cavity primaries
Number of subjects: 500
Study 6345489 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial T or N-stage
Number of subjects: 500
Study 31111942 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimonials (one to two courses)
Number of subjects: 48
Study 28295985 — intervention group
Group type: EXPERIMENTAL
Intervention: NT-proBNP-guided therapy
Number of subjects: 622
Study 28295985 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 622
Study 26349872 — intervention group
Group type: EXPERIMENTAL
Intervention: Central venous access devices (CVADs)
Number of subjects: 32
Study 26349872 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical staff perspectives
Number of subjects: 32
Study 22937895 — intervention group
Group type: EXPERIMENTAL
Intervention: Taspoglutide 10 mg once weekly
Number of subjects: 1049
Study 22937895 — intervention group
Group type: EXPERIMENTAL
Intervention: Taspoglutide 20 mg once weekly
Number of subjects: 1049
Study 22937895 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine once daily
Number of subjects: 1049
Study 21269722 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated vaccination at 0, 1, 4 and 8 weeks
Number of subjects: 180
Study 21269722 — intervention group
Group type: COMPARATOR
Intervention: Classic vaccination at 0, 1 and 6 months
Number of subjects: 180
Study 19969179 — intervention group
Group type: EXPERIMENTAL
Intervention: Body weight-supported treadmill training (BWSTT)
Number of subjects: 21
Study 19969179 — intervention group
Group type: COMPARATOR
Intervention: Standard walking exercises
Number of subjects: 21
Study 17596432 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccination with HPV L1 VLP
Number of subjects: 26
Study 17596432 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 15577784 — intervention group
Group type: EXPERIMENTAL
Intervention: Famciclovir
Number of subjects: 23
Study 15577784 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 11265884 — intervention group
Group type: EXPERIMENTAL
Intervention: Tunneled pleural catheters (TPCs)
Number of subjects: 28
Study 9233203 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast cleansing with Phisoderm and tap water
Number of subjects: 178
Study 9233203 — intervention group
Group type: COMPARATOR
Intervention: Breast cleansing with tap water only
Number of subjects: 178
Study 8425992 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantitative angiographic variable - minimal lumen diameter
Number of subjects: 350
Study 8425992 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantitative angiographic variable - percent diameter stenosis
Number of subjects: 350
Study 8425992 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantitative angiographic variable - change in minimal lumen diameter
Number of subjects: 350
Study 8425992 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantitative angiographic variable - change in percent diameter stenosis
Number of subjects: 350
Study 2831117 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (20 to 40 mg/day for 8 weeks)
Number of subjects: 32
Study 2831117 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 2831117 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 32
Study 31786590 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegetarian lunch-default (Group 2)
Number of subjects: 330
Study 31786590 — intervention group
Group type: COMPARATOR
Intervention: Non-vegetarian lunch-default (Group 1)
Number of subjects: 330
Study 31786590 — intervention group
Group type: EXPERIMENTAL
Intervention: Nudge acceptance
Number of subjects: 330